AR018706A1 - Uso de una composicion farmaceutica para tratamiento de infecciones virales - Google Patents

Uso de una composicion farmaceutica para tratamiento de infecciones virales

Info

Publication number
AR018706A1
AR018706A1 ARP000101501A ARP000101501A AR018706A1 AR 018706 A1 AR018706 A1 AR 018706A1 AR P000101501 A ARP000101501 A AR P000101501A AR P000101501 A ARP000101501 A AR P000101501A AR 018706 A1 AR018706 A1 AR 018706A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
treatment
viral infections
formula
ofluoro
Prior art date
Application number
ARP000101501A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR018706A1 publication Critical patent/AR018706A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composicion farmacéutica que inhibe o detiene el crecimiento de virus, comprende de 10 mg a 6000 mg, aproximadamente de 2-tienil-imidazolo [4,5]piridina de la formula (I) en donde n es 1-4, R se selecciona del grupo que consiste de hidrogeno,alq uilo que tiene de 1 a 7 átomos de carbono, cloro, bromo ofluoro, oxicloro, hidroxi, sulfhidrilo, y alcoxi que tiene la formula -O(CH2)yCH3 en donde y es de 1 a 6, las prodrogas de esta y las sales farmacéuticamenteaceptables de esta.
ARP000101501A 1999-03-31 2000-03-31 Uso de una composicion farmaceutica para tratamiento de infecciones virales AR018706A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28189299A 1999-03-31 1999-03-31

Publications (1)

Publication Number Publication Date
AR018706A1 true AR018706A1 (es) 2001-11-28

Family

ID=23079205

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101501A AR018706A1 (es) 1999-03-31 2000-03-31 Uso de una composicion farmaceutica para tratamiento de infecciones virales

Country Status (11)

Country Link
US (2) US6194430B1 (es)
EP (1) EP1165077B1 (es)
JP (1) JP2002540151A (es)
AR (1) AR018706A1 (es)
AT (1) ATE298569T1 (es)
AU (1) AU763431B2 (es)
CA (1) CA2365495C (es)
CO (1) CO5160292A1 (es)
DE (1) DE60021065T2 (es)
NZ (1) NZ514558A (es)
WO (1) WO2000057870A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969367B2 (en) * 2000-02-02 2005-11-29 Xepmed, Inc. Extracorporeal pathogen reduction system
US6613507B1 (en) 2000-03-21 2003-09-02 Yu-an Chang Boraadamantane compounds for the treatment of pathogenic viruses and other medical applications
CN1187052C (zh) 2000-03-30 2005-02-02 布里斯托尔-迈尔斯斯奎布公司 含有司他夫定(stavudine)的持续释放微球
WO2001097749A2 (en) * 2000-06-23 2001-12-27 Kotze, Gavin, Salomon The use of synthetic, non-hormonal 21-aminosteroids and thereof
WO2002041891A2 (en) * 2000-11-01 2002-05-30 The Procter & Gamble Company Hiv treatment with benzimidazoles
JP2005521712A (ja) * 2002-03-26 2005-07-21 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ 弱塩基の可溶化
EP2357009A1 (en) * 2002-07-15 2011-08-17 Board of Regents, The University of Texas System Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
US7678386B2 (en) * 2002-07-15 2010-03-16 Board Of Regents The University Of Texas Liposomes coated with selected antibodies that bind to aminophospholipids
US7615223B2 (en) * 2002-07-15 2009-11-10 Board Of Regents, The University Of Texas System Selected immunoconjugates for binding to aminophospholipids
US7714109B2 (en) * 2002-07-15 2010-05-11 Board Of Regents, The University Of Texas System Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
US7625563B2 (en) * 2002-07-15 2009-12-01 Board Of Regents, The University Of Texas System Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids
US7622118B2 (en) * 2002-07-15 2009-11-24 Board Of Regents, The University Of Texas System Cancer treatment methods using selected antibodies to aminophospholipids
US7572448B2 (en) * 2002-07-15 2009-08-11 Board Of Regents, The University Of Texas System Combined cancer treatment methods using selected antibodies to aminophospholipids
US20070053883A1 (en) * 2003-03-25 2007-03-08 The Johns Hopkins University Neuronal cell lineages and methods of production thereof
US20080027575A1 (en) * 2006-04-21 2008-01-31 Jones Stevan D Modeling systems for health and beauty consumer goods
CN110294751B (zh) * 2018-03-21 2020-11-20 湖南化工研究院有限公司 具生物活性的咪唑[4,5-b]并吡啶类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3590045A (en) 1969-09-25 1971-06-29 Smith Kline French Lab Certain substituted imidazo (4,5-b)pyridines
IL37752A (en) 1970-09-21 1974-10-22 Rhone Poulenc Sa Imidazo(4,5-b)pyridine-2-carbamic acid derivatives,processes for their preparation and pharmaceutical and veterinary compositions containing the same
AT379395B (de) * 1983-11-14 1985-12-27 Laevosan Gmbh & Co Kg Verfahren zur herstellung von neuen 2(2-thienyl)-imidazo (4,5-b) pyridin-derivaten und deren pharmazeutisch vertraeglichen saeureadditionssalzen
DE3722992A1 (de) * 1987-07-11 1989-01-19 Thomae Gmbh Dr K Neue imidazo-pyridine und purine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP1165077A2 (en) 2002-01-02
DE60021065D1 (de) 2005-08-04
NZ514558A (en) 2004-02-27
AU4048900A (en) 2000-10-16
US6194430B1 (en) 2001-02-27
WO2000057870A3 (en) 2001-03-08
WO2000057870A2 (en) 2000-10-05
AU763431B2 (en) 2003-07-24
ATE298569T1 (de) 2005-07-15
US20030232851A1 (en) 2003-12-18
EP1165077B1 (en) 2005-06-29
DE60021065T2 (de) 2006-06-01
CA2365495C (en) 2007-01-02
JP2002540151A (ja) 2002-11-26
CO5160292A1 (es) 2002-05-30
CA2365495A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
AR018706A1 (es) Uso de una composicion farmaceutica para tratamiento de infecciones virales
NZ514873A (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
AR024077A1 (es) Compuestos antibacterianos
AR019305A1 (es) Hiv y tratamiento viral.
CR7510A (es) DERIVADOS DE [1-4] DIAZEPINO[6,7,1-iJ)] QUINOLONA COMO AGENTES ANTIPSICOTICOS Y CONTRA LA OBESIDAD
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
CO5280060A1 (es) Aminoacidos biciclicos como agentes farmaceuticos
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
KR930703303A (ko) 1, 4-벤조티아제핀 유도체
EA200400007A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ
BRPI0412502A (pt) derivados de ariltiouréia substituìda úteis como inibidores de replicação viral
PE20010541A1 (es) Uso de una composicion de benzimidazol para tratar el cancer
AR014964A1 (es) Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
AR035110A1 (es) Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto
AR016382A1 (es) Uso de un derivado del acido bencil-indazol metoxialcanoico.
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
KR880007462A (ko) 빈뇨치료용 프로피오페논 유도체
PA8450901A1 (es) Derivados de eritromicina
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
AR018707A1 (es) Composicion farmaceutica para tratar infecciones virales
ATE234320T1 (de) Beta,beta-disubstituierte derivate von 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a

Legal Events

Date Code Title Description
FA Abandonment or withdrawal